Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know.
1PCI, used appropriately (including some subsets of multivessel disease and left main stem stenosis) can be a very effective and worthwhile intervention. My criticisms, however, are aimed at its increasing, inappropriate, and non-evidence-based use in the wider population of patients with multivesse...
Κύριος συγγραφέας: | Taggart, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2006
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease
ανά: Hristo Kirov, κ.ά.
Έκδοση: (2023-12-01) -
Plastics of the left ventricle aneurysm with minimally invasive multivessel coronary artery bypass grafting
ανά: V.M. Demianenko, κ.ά.
Έκδοση: (2019-10-01) -
Features of Cardiopulmonary Bypass in Mininvasive Multivessel Coronary Artery Bypass Grafting
ανά: V. M. Demianenko, κ.ά.
Έκδοση: (2019-05-01) -
Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease.
ανά: Taggart, D
Έκδοση: (2011) -
Coronary-artery bypass surgery versus stenting for multivessel disease.
ανά: Taggart, D, κ.ά.
Έκδοση: (2001)